Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

A Composite Disease Activity Scale for Clinical Practice, Observational Studies, and Clinical Trials: The Patient Activity Scale (PAS/PAS-II)

FREDERICK WOLFE, KALEB MICHAUD, and THEODORE PINCUS

ABSTRACT.

Objective.
To develop and validate a composite patient self-report disease activity scale for use in clinical practice and in observational studies and clinical trials.

Methods. A total of 9078 patients with rheumatoid arthritis completed detailed questionnaires that included measure of quality of life in the form of utilities. We evaluated several disease activity scales by measuring their agreement with the utility scales, and also their assessed ability to predict mortality and prescription for anti-tumor necrosis factor therapy.

Results. A composite index composed of a visual analog scale (VAS) for pain, a patient global VAS, and the Health Assessment Questionnaire (HAQ) or the HAQ II formed the Patient Activity Scale (PAS) and PAS-II. These scales performed as well as or better than longer, more complex scales.

Conclusion. A simple, useful clinical scale, the PAS or PAS-II, can be formed by the use of common clinical variables. It is well correlated with and relevant to a wide range of clinical variables. This scale should be useful for comparative studies, clinical care, and regulatory documentation. (J Rheumatol 2005;32:2410-5)

Key Indexing Terms:

PATIENT ACTIVITY SCALE
HEALTH ASSESSMENT QUESTIONNAIRE
DISEASE ACTIVITY
VISUAL ANALOG SCALE


From the National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas; Center for Primary Care and Outcomes Research, Stanford University, Stanford, California; and the Division of Rheumatology, Vanderbilt University, Nashville, Tennessee, USA.

F. Wolfe, MD, National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine; K. Michaud, MS, National Data Bank for Rheumatic Diseases and Stanford University; T. Pincus, MD, Division of Rheumatology, Vanderbilt University.

Address correspondence to Dr. F. Wolfe, National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, 1035 N. Emporia, Suite 230, Wichita, KS 67214. E-mail: fwolfe@arthritis-research.org

Accepted for publication July 25, 2005.




Return to December 2005 Table of Contents



© 2005. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.